{
    "title": "Generic Drug Pricing Fairness Act",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Generic Drug Pricing Fairness Act''.\n\nSEC. 2. PHARMACY BENEFITS MANAGER STANDARDS UNDER THE MEDICARE PROGRAM.\n\n    (a) In General.--Section 1860D-12(b) of the Social Security Act (42 \nU.S.C. 1395w-112(b)) is amended by adding at the end the following new \nparagraph:\n            ``(7) Pharmacy benefits manager transparency \n        requirements.--Each contract entered into with a PDP sponsor \n        under this part with respect to a prescription drug plan \n        offered by such sponsor shall provide that the PDP may not \n        enter into a contract with any pharmacy benefits manager \n        (referred to in this paragraph as a `PBM') to manage the \n        prescription drug coverage provided under such plan, or to \n        control the costs of the prescription drug coverage under such \n        plan, unless the PBM adheres to the following criteria when \n        handling personally identifiable utilization and claims data or \n        other sensitive patient data:\n                    ``(A) The PBM may not transmit any personally \n                identifiable utilization or claims data, with respect \n                to a plan enrollee, to a pharmacy owned by a PBM if the \n                plan enrollee has not voluntarily elected in writing or \n                via secure electronic means to fill that particular \n                prescription at the PBM-owned pharmacy.\n                    ``(B) The PBM may not require that a plan enrollee \n                use a retail pharmacy, mail order pharmacy, specialty \n                pharmacy, or other pharmacy entity providing pharmacy \n                services in which the PBM has an ownership interest or \n                that has an ownership interest in the PBM or provide an \n                incentive to a plan enrollee to encourage the enrollee \n                to use a retail pharmacy, mail order pharmacy, \n                specialty pharmacy, or other pharmacy entity providing \n                pharmacy services in which the PBM has an ownership \n                interest or that has an ownership interest in the PBM, \n                if the incentive is applicable only to such \n                pharmacies.''.\n    (b) Regular Update of Prescription Drug Pricing Standard.--\nParagraph (6) of section 1860D-12(b) of the Social Security Act (42 \nU.S.C. 1395w-112(b)) is amended to read as follows:\n            ``(6) Regular update of prescription drug pricing \n        standard.--\n                    ``(A) In general.--If the PDP sponsor of a \n                prescription drug plan uses a standard for \n                reimbursement (as described in subparagraph (B)) of \n                pharmacies based on the cost of a drug, each contract \n                entered into with such sponsor under this part with \n                respect to the plan shall provide that the sponsor \n                shall--\n                            ``(i) update such standard not less \n                        frequently than once every 7 days, beginning \n                        with an initial update on January 1 of each \n                        year, to accurately reflect the market price of \n                        acquiring the drug;\n                            ``(ii) disclose to applicable pharmacies \n                        the sources used for making any such update;\n                            ``(iii) if the source for such a standard \n                        for reimbursement is not publicly available, \n                        disclose to the applicable pharmacies all \n                        individual drug prices to be so updated in \n                        advance of the use of such prices for the \n                        reimbursement of claims; and\n                            ``(iv) establish a process to appeal, \n                        investigate, and resolve disputes regarding \n                        individual drug prices that are less than the \n                        pharmacy acquisition price for such drug.\n                    ``(B) Prescription drug pricing standard defined.--\n                For purposes of subparagraph (A), a standard for \n                reimbursement of a pharmacy is any methodology or \n                formula for varying the pricing of a drug or drugs \n                during the term of the pharmacy reimbursement contract \n                that is based on the cost of the drug involved, \n                including drug pricing references and amounts that are \n                based upon average wholesale price, wholesale average \n                cost, average manufacturer price, average sales price, \n                maximum allowable cost (MAC), or other costs, whether \n                publicly available or not.''.\n    (c) Effective Date.--The amendments made by this section shall \napply to plan years beginning on or after January 1, 2015.\n\nSEC. 3. REGULAR UPDATE OF PRESCRIPTION DRUG PRICING STANDARD UNDER \n              TRICARE RETAIL PHARMACY PROGRAM.\n\n    Section 1074g(d) of title 10, United States Code, is amended by \nadding at the end the following new paragraph:\n    ``(3) To the extent practicable, with respect to the TRICARE retail \npharmacy program described in subsection (a)(2)(E)(ii), the Secretary \nshall ensure that a contract entered into with a TRICARE managed care \nsupport contractor includes requirements described in section 1860D-\n12(b)(6) of the Social Security Act (42 U.S.C. 1395w-112(b)(6)) to \nensure the provision of information regarding the pricing standard for \nprescription drugs.''.\n\nSEC. 4. PRESCRIPTION DRUG TRANSPARENCY IN THE FEDERAL EMPLOYEE HEALTH \n              BENEFITS PROGRAM.\n\n    (a) In General.--Section 8902 of title 5, United States Code, is \namended by adding at the end the following new subsections:\n    ``(p) A contract may not be made or a plan approved under this \nchapter under which a carrier has an agreement with a pharmacy benefits \nmanager (in this subsection referred to as a `PBM') to manage \nprescription drug coverage or to control the costs of the prescription \ndrug coverage unless the carrier and PBM adhere to the following \ncriteria:\n            ``(1) The PBM may not transmit any personally identifiable \n        utilization or claims data with respect to an individual \n        enrolled under such contract or plan to a pharmacy owned by the \n        PBM if the individual has not voluntarily elected in writing or \n        via secure electronic means to fill that particular \n        prescription at such a pharmacy.\n            ``(2) The PBM may not require that an individual enrolled \n        under such contract or plan use a retail pharmacy, mail order \n        pharmacy, specialty pharmacy, or other pharmacy entity \n        providing pharmacy services in which the PBM has an ownership \n        interest or that has an ownership interest in the PBM or \n        provide an incentive to a plan enrollee to encourage the \n        enrollee to use a retail pharmacy, mail order pharmacy, \n        specialty pharmacy, or other pharmacy entity providing pharmacy \n        services in which the PBM has an ownership interest or that has \n        an ownership interest in the PBM, if the incentive is \n        applicable only to such pharmacies.\n    ``(q)(1) If a contract made or plan approved under this chapter \nprovides for a standard for reimbursement (as described in paragraph \n(2)) with respect to a prescription drug plan, such contract or plan \nshall provide that the applicable carrier--\n            ``(A) update such standard not less frequently than once \n        every 7 days, beginning with an initial update on January 1 of \n        each year, to accurately reflect the market price of acquiring \n        the drug;\n            ``(B) disclose to applicable pharmacies the sources used \n        for making any such update;\n            ``(C) if the source for such a standard for reimbursement \n        is not publicly available, disclose to the applicable \n        pharmacies all individual drug prices to be so updated in \n        advance of the use of such prices for the reimbursement of \n        claims; and\n            ``(D) establish a process to appeal, investigate, and \n        resolve disputes regarding individual drug prices that are less \n        than the pharmacy acquisition price for such drug.\n    ``(2) For purposes of paragraph (1), a standard for reimbursement \nof a pharmacy is any methodology or formula for varying the pricing of \na drug or drugs during the term of the pharmacy reimbursement contract \nthat is based on the cost of the drug involved, including drug pricing \nreferences and amounts that are based upon average wholesale price, \nwholesale average cost, average manufacturer price, average sales \nprice, maximum allowable cost, or other costs, whether publicly \navailable or not.''.\n    (b) Application.--The amendment made by subsection (a) shall apply \nto any contract entered into under section 8902 of title 5, United \nStates Code, on or after the date of enactment of this section."
}